Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kororo mouthwash is an antiseptic gargle solution developed by Saraya Co., Ltd., primarily used for oral hygiene and the prevention of throat infections. Its active ingredient is typically lauryldiaminoethylglycine sodium, an amphoteric surfactant that provides bactericidal and cleaning actions. It is designed to disinfect the mouth and throat while removing odors and providing a refreshing sensation through the inclusion of l-menthol. In Japan, it is classified as a quasi-drug and is commonly found in public dispensing stations, offices, and healthcare facilities. The formulation is intended to be mild, making it suitable for frequent use without the harshness associated with some other antiseptic gargles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kororo mouthwash.